EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Novelty seeking and rapid symptom improvement across active and sham accelerated iTBS conditions: A pooled individual-patient data analysis

Cecilia Chiarenza, Beatriz Araújo Cavendish, Deng Mao, Yichen Zhang, Kevin La Monica, Guo-Rong Wu, Sara De Witte, Paula Horczak, Cisse Geleyn, Maria Salvina Signorelli, Carmen Concerto, Laís Boralli Razza und 1 weitere

Journal of Affective Disorders · 2026-12 · 414 · 122406

DOI: 10.1016/j.jad.2026.122406 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026-12. Verfasst von Cecilia Chiarenza und 12 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, 95123, Italy; Ghent Experimental Psychiatry (GHEP)…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Exploratory Behavior, Depressive Disorder, Treatment-Resistant, Transcranial Magnetic Stimulation. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Federal Railroad Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Major depressive disorder (MDD) is highly prevalent and often treatment-resistant. Accelerated intermittent theta burst stimulation (aiTBS) is a promising intervention for treatment-resistant depression (TRD), though outcomes vary. Personality traits have been examined in relation to rTMS outcomes, yet their role in aiTBS remains underexplored. This pooled individual-patient-data analysis of two randomized, sham-controlled trials examined associations between baseline Temperament and Character Inventory (TCI) traits and one-week symptom change, and whether they differed by condition. METHODS: The left dorsolateral prefrontal cortex was targeted for 20 sessions over 4 days. Personality was assessed with the TCI, depression severity with the 17-item Hamilton Depression Rating Scale (HDRS-17). TCI-symptom-change associations were examined with a robust linear mixed-effects model, adjusting for age, gender, repeated measurements, and study membership. RESULTS: 104 participants were included (M/F 45/59; mean age 40.9 ± 12.7; active/sham 50/54). The model yielded a Time × Novelty Seeking interaction (β = -1.70, p = 0.021): higher baseline Novelty Seeking was associated with faster symptom reduction, without a between-arm difference. However, the interaction did not survive Holm correction across 14 trait-interaction tests (adjusted p = 0.294) and is therefore exploratory. No other interaction reached the uncorrected threshold. CONCLUSIONS: Higher baseline Novelty Seeking showed a nominal association with faster symptom reduction, without a difference between active and sham conditions. Because it did not survive multiplicity correction and was not reproduced in within-arm analyses, it is preliminary and may reflect contextual or nonspecific processes. Independent replication is required before temperament assessment can be clinically informative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderExploratory BehaviorDepressive Disorder, Treatment-ResistantTranscranial Magnetic StimulationHumansFemaleMaleAdultTemperamentMiddle AgedTreatment OutcomeDorsolateral Prefrontal CortexPersonality InventoryPsychiatric Status Rating ScalesCharacter

Stichwörter der Autor:innen

Accelerated iTBSFast responseNovelty seekingTCITreatment-resistant depression

Autor:innen und Institutionen

  • Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, 95123, Italy; Ghent Experimental Psychiatry (GHEP) lab, Faculty of Medicine and Health Sciences, Department of Head and…
  • Ghent Experimental Psychiatry (GHEP) lab, Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Ghent, Belgium; Service of Interdisciplinary Neuromodulation, Department and Institute of…
  • Ghent Experimental Psychiatry (GHEP) lab, Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Ghent, Belgium.
  • University of Milan, Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, Milan, Italy.
  • Ghent Experimental Psychiatry (GHEP) lab, Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Ghent, Belgium; Neuroprotection and Neuromodulation Research Group (NEUR), Center for Neu…
  • Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, 95123, Italy.

Förderung

  • National Natural Science Foundation of China
  • Federal Railroad Administration

Zitieren

APA

Chiarenza, C., Cavendish, B. A., Mao, D., Zhang, Y., La Monica, K., Wu, G. R., De Witte, S., Horczak, P., Geleyn, C., Signorelli, M. S., Concerto, C., Razza, L. B., & Baeken, C. (2026). Novelty seeking and rapid symptom improvement across active and sham accelerated iTBS conditions: A pooled individual-patient data analysis. Journal of Affective Disorders, 414, 122406. https://doi.org/10.1016/j.jad.2026.122406

Vancouver

Chiarenza C, Cavendish BA, Mao D, Zhang Y, La Monica K, Wu GR, et al. Novelty seeking and rapid symptom improvement across active and sham accelerated iTBS conditions: A pooled individual-patient data analysis. Journal of Affective Disorders. 2026;414:122406. doi:10.1016/j.jad.2026.122406

BibTeX
@article{Chiarenza2026,
  author = {Chiarenza, Cecilia and Cavendish, Beatriz Araújo and Mao, Deng and Zhang, Yichen and La Monica, Kevin and Wu, Guo-Rong and De Witte, Sara and Horczak, Paula and Geleyn, Cisse and Signorelli, Maria Salvina and Concerto, Carmen and Razza, Laís Boralli and Baeken, Chris},
  title = {Novelty seeking and rapid symptom improvement across active and sham accelerated iTBS conditions: A pooled individual-patient data analysis},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {414},
  pages = {122406},
  doi = {10.1016/j.jad.2026.122406}
}
Kostenlos starten →